Singapore markets closed
  • Straits Times Index

    3,140.20
    -42.21 (-1.33%)
     
  • S&P 500

    4,188.43
    -44.17 (-1.04%)
     
  • Dow

    34,742.82
    -34.98 (-0.10%)
     
  • Nasdaq

    13,401.86
    -350.34 (-2.55%)
     
  • BTC-USD

    55,724.84
    -2,468.99 (-4.24%)
     
  • CMC Crypto 200

    1,478.48
    -82.82 (-5.30%)
     
  • FTSE 100

    6,980.20
    -143.48 (-2.01%)
     
  • Gold

    1,835.30
    -2.30 (-0.13%)
     
  • Crude Oil

    64.49
    -0.43 (-0.66%)
     
  • 10-Yr Bond

    1.6020
    0.0000 (0.00%)
     
  • Nikkei

    28,608.59
    -909.71 (-3.08%)
     
  • Hang Seng

    28,013.81
    -581.89 (-2.03%)
     
  • FTSE Bursa Malaysia

    1,577.64
    -6.28 (-0.40%)
     
  • Jakarta Composite Index

    5,938.35
    -37.44 (-0.63%)
     
  • PSE Index

    6,326.83
    +9.42 (+0.15%)
     

Global Alpha 1 Antitrypsin Deficiency Treatment Market Report 2021-2027 - ResearchAndMarkets.com

·3-min read

The "Alpha 1 Antitrypsin Deficiency Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Alpha 1 Antitrypsin Deficiency Treatment Market to Reach $2.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Alpha 1 Antitrypsin Deficiency Treatment estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027.

Augmentation Therapy, one of the segments analyzed in the report, is projected to record a 9.7% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bronchodilator segment is readjusted to a revised 9.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $463.6 Million, While China is Forecast to Grow at 8.3% CAGR

The Alpha 1 Antitrypsin Deficiency Treatment market in the U.S. is estimated at US$463.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$493.1 Million by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Corticosteroids Segment to Record 7.7% CAGR

In the global Corticosteroids segment, USA, Canada, Japan, China and Europe will drive the 7.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$189.6 Million in the year 2020 will reach a projected size of US$319.9 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$328.4 Million by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 46 Featured):

  • Abeona Therapeutics Inc.

  • Applied Genetic Technologies Corporation

  • Arrowhead Pharmaceuticals Inc.

  • AstraZeneca PLC

  • Baxter International, Inc.

  • Biogen, Inc.

  • Boehringer Ingelheim International GmbH

  • Chiesi Farmaceutici SpA

  • CSL Behring

  • Curaxys

  • GlaxoSmithKline PLC

  • Grifols International SA

  • Kamada Ltd.

  • Pfizer, Inc.

  • ProBioGen AG

  • ProMetic Life Sciences, Inc.

  • Shire PLC

  • Teva Pharmaceutical Industries Ltd.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • United States

  • Canada

  • Japan

  • China

  • Europe

  • France

  • Germany

  • Italy

  • United Kingdom

  • Spain

  • Russia

  • Rest Of Europe

  • Asia-Pacific

  • Australia

  • India

  • South Korea

  • Rest Of Asia-Pacific

  • Latin America

  • Argentina

  • Brazil

  • Mexico

  • Rest Of Latin America

  • Middle East

  • Iran

  • Israel

  • Saudi Arabia

  • United Arab Emirates

  • Rest Of Middle East

  • Africa

IV. COMPETITION

  • Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/f89cy3

View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005918/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900